Intracellular P-gp contributes to functional drug efflux and resistance in acute myeloid leukaemia
- 5 April 2001
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 25 (5) , 395-405
- https://doi.org/10.1016/s0145-2126(00)00156-9
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Clinical relevance of transmembrane drug efflux as a mechanism of multidrug resistance.Journal of Clinical Oncology, 1998
- The P-Glycoprotein Efflux Pump: How Does it Transport Drugs?The Journal of Membrane Biology, 1997
- Classical multidrug resistance in acute myeloid leukaemiaMedical Oncology, 1997
- Molecular analysis of the multidrug transporterCytotechnology, 1993
- Expression of Multidrug Resistance Gene in Human CancersJNCI Journal of the National Cancer Institute, 1989
- A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells.Proceedings of the National Academy of Sciences, 1988
- Acute myelogenous leukemia: recent advances in therapyBlood, 1987
- Multiple-Drug Resistance in Human CancerNew England Journal of Medicine, 1987
- Isolation and expression of a complementary DNA that confers multidrug resistanceNature, 1986
- Amplification of DNA sequences in human multidrug-resistant KB carcinoma cells.Proceedings of the National Academy of Sciences, 1985